Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model

PLoS Medicine

Volumn 14, Issue 2, 2017, Pages

  Walker, Patrick G T ^a   Floyd, Jessica ^a   ter Kuile, Feiko ^b,c   Cairns, Matt ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; DRUG COMBINATION; FANASIL, PYRIMETHAMINE DRUG COMBINATION; PYRIMETHAMINE; SULFADOXINE;

ADULT; AFRICA; ARTICLE; BIRTH WEIGHT; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; FEMALE; FREQUENCY ANALYSIS; GENE FREQUENCY; GENE MUTATION; HAPLOTYPE; HUMAN; INTERVENTION STUDY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALARIA; MATHEMATICAL MODEL; MIDDLE AGED; NEWBORN ANEMIA; PARASITOLOGY; PLASMODIUM FALCIPARUM; PREGNANCY; PRENATAL CARE; PREVALENCE; PROBABILITY; SPONTANEOUS ABORTION; YOUNG ADULT; AFRICA SOUTH OF THE SAHARA; CHILD; DRUG COMBINATION; MULTIDRUG RESISTANCE; PRESCHOOL CHILD; THEORETICAL MODEL;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; BIRTH WEIGHT; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MALARIA; MODELS, THEORETICAL; PREGNANCY; PYRIMETHAMINE; SULFADOXINE;

EID: 85014482558     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1002243     Document Type: Article

References (47)

1. Alonso PL, Tanner M, Public health challenges and prospects for malaria control and elimination. Nat Med. 2013;19:150–5. doi: 10.1038/nm.307723389615
2. Steketee RW, Nahlen BL, Parise ME, Menendez C, The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg. 2001;64:28.
3. Guyatt HL, Snow RW, Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev. 2004;17:760–9. doi: 10.1128/CMR.17.4.760-769.200415489346
4. Guyatt HL, Snow RW, Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2001;95:569–76. 11816423
5. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207–11. doi: 10.1038/nature1553526375008
6. World Health Organization. World Malaria Report 2015. Geneva: World Health Organization; 2015 [cited 2017 Jan 26]. Available from: http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/.
7. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7:93–104. doi: 10.1016/S1473-3099(07)70021-X17251080
8. Van Eijk AM, Ayisi JG, ter Kuile FO, Otieno JA, Misore AO, Odondi JO, et al. Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. Trop Med Int Health. 2004;9:351–60. 14996364
9. Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA. 2013;309:594–604. doi: 10.1001/jama.2012.21623123403684
10. Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, et al. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis. 2012;12:942–9. doi: 10.1016/S1473-3099(12)70222-022995852
11. Ter Kuile FO, van Eijk AM, Filler SJ, Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007;297:2603–16. doi: 10.1001/jama.297.23.260317579229
12. Fernandes S, Sicuri E, Kayentao K, van Eijk AM, Hill J, Webster J, et al. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data. Lancet Glob Heal. 2015;3:e143–53.
13. Walker PGT, ter Kuile FO, Garske T, Menendez C, Ghani AC, Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study. Lancet Glob Heal. 2014;2:e460–7.
14. Van Eijk AM, Hill J, Larsen DA, Webster J, Steketee RW, Eisele TP, et al. Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009–11. Lancet Infect Dis. 2013;13(12):1029–42. doi: 10.1016/S1473-3099(13)70199-324054085
15. Chico RM, Dellicour S, Roman E, Mangiaterra V, Coleman J, Menendez C, et al. Global Call to Action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa. Malar J. 2015;14:207. doi: 10.1186/s12936-015-0728-x25986063
16. Nosten F, McGready R, Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective. Malar J. 2015;14:248. doi: 10.1186/s12936-015-0765-526088554
17. Harrington W, McGready R, Muehlenbachs A, Fried M, Nosten F, Duffy P, Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine: the times they are a-changin’. Clin Infect Dis. 2012;55:1025–6. doi: 10.1093/cid/cis56822715177
18. Harrington WE, Fried M, Duffy PE, Defending the use of sulfadoxine-pyrimethamine for intermittent preventive treatment for malaria in pregnancy: a short-sighted strategy. J Infect Dis. 2015;213(3):496–7. doi: 10.1093/infdis/jiv42026290607
19. Mugittu K, Abdulla S, Falk N, Masanja H, Felger I, Mshinda H, et al. Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies. Malar J. 2005;4:55. doi: 10.1186/1475-2875-4-5516297234
20. Griffin JT, Cairns M, Ghani AC, Roper C, Schellenberg D, Carneiro I, et al. Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance. PLoS ONE. 2010;5:e12618. doi: 10.1371/journal.pone.001261820838642
21. Naidoo I, Roper C, Mapping “partially resistant”, “fully resistant”, and “super resistant” malaria. Trends Parasitol. 2013;29:505–15. doi: 10.1016/j.pt.2013.08.00224028889
22. Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, et al. Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clin Infect Dis. 2016;62:323–33. doi: 10.1093/cid/civ88126486699
23. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE, Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis. 2011;53:224–30. doi: 10.1093/cid/cir37621765070
24. Gutman J, Kalilani L, Taylor S, Zhou Z, Wiegand RE, Thwai KL, et al. Plasmodium falciparum dihydropteroate synthetase-A581G mutation reduces effectiveness of sulfadoxine-pyrimethamine preventive therapy in Malawian pregnant women. J Infect Dis. 2015;211(12):1997–2005. doi: 10.1093/infdis/jiu83625564249
25. Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M, et al. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci U S A. 2009;106:9027–32. doi: 10.1073/pnas.090141510619451638
26. Wolfe EB, Parise ME, Haddix AC, Nahlen BL, Ayisi JG, Misore A, et al. Cost-effectiveness of sulfadoxine-pyrimethamine for the prevention of malaria-associated low birth weight. Am J Trop Med Hyg. 64:178–86. 11442215
27. Mbonye AK, Hansen KS, Bygbjerg IC, Magnussen P, Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda. Trans R Soc Trop Med Hyg. 2008;102:685–93. doi: 10.1016/j.trstmh.2008.04.01618513767
28. Hansen KS, Ndyomugyenyi R, Magnussen P, Clarke SE, Cost-effectiveness analysis of three health interventions to prevent malaria in pregnancy in an area of low transmission in Uganda. Int Health. 2012;4:38–46. doi: 10.1016/j.inhe.2011.10.00124030879
29. Flegg JA, Patil AP, Venkatesan M, Roper C, Naidoo I, Hay SI, et al. Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum. Malar J. 2013;12:249. doi: 10.1186/1475-2875-12-24923866695
30. The DHS Program: Demographic and Health Surveys. Rockville (Maryland): ICF International; 2017 [cited 2017 Feb 2]. Available from: http://dhsprogram.com/
31. Oak Ridge National LaboratoryLandScan. Oak Ridge (Tennessee): Oak Ridge National Laboratory; 2017 [cited 2017 Feb 2]. Available from: http://www.ornl.gov/sci/landscan/.
32. Population prospects for the twenty-first century: the 2010 United Nations projections. Popul Dev Rev. 2011;37:407–11.
33. Walker PGT, Griffin JT, Cairns M, Rogerson SJ, van Eijk AM, Ter Kuile F, et al. A model of parity-dependent immunity to placental malaria. Nat Commun. 2013;4:1609. doi: 10.1038/ncomms260523511473
34. Van Eijk AM, Hill J, Alegana VA, Kirui V, Gething PW, Ter Kuile FO, et al. Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data. Lancet Infect Dis. 2011;11:190–207. doi: 10.1016/S1473-3099(10)70295-421273130
35. Kayentao K, Kodio M, Newman RD, Maiga H, Doumtabe D, Ongoiba A, et al. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis. 2005;191:109–16. doi: 10.1086/42640015593011
36. Challis K, Osman NB, Cotiro M, Nordahl G, Dgedge M, Bergström S, Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique. Trop Med Int Health. 2004;9:1066–73. doi: 10.1111/j.1365-3156.2004.01307.x15482398
37. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg. 1998;59:813–22. 9840604
38. Njagi JK, Magnussen P, Estambale B, Ouma J, Mugo B, Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: a randomized controlled trial. Trans R Soc Trop Med Hyg. 97:277–82. 15228241
39. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, Wirima JJ, The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg. 1994;51:515–22. 7985742
40. Ter Kuile FO, Terlouw DJ, Phillips-Howard PA, Hawley WA, Friedman JF, Kariuki SK, et al. Reduction of malaria during pregnancy by permethrin-treated bed nets in an area of intense perennial malaria transmission in western Kenya. Am J Trop Med Hyg. 2003;68:50–60. 12749486
41. Njagi JK. The effects of sulfadoxine-pyrimethamine intermittent treatment and pyrethroid impregnated bed nets on malaria morbidity and birth weight in Bondo district, Kenya [dissertation]. Nairobi: University of Nairobi; 2002.
42. Gamble C, Ekwaru PJ, Garner P, ter Kuile FO, Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomised controlled trials. PLoS Med. 2007;4:e107. doi: 10.1371/journal.pmed.004010717388668
43. Cairns M, Carneiro I, Milligan P, Owusu-Agyei S, Awine T, Gosling R, et al. Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana. PLoS ONE. 2008;3:e2227. doi: 10.1371/journal.pone.000222718493597
44. Walker PGT, ter Kuile FO, Garske T, Menendez C, Ghani AC, Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study. Lancet Glob Heal. 2014;2:e460–7.
45. Mayor A, Bardají A, Macete E, Nhampossa T, Fonseca AM, González R, et al. Changing trends in P. falciparum burden, immunity, and disease in pregnancy. N Engl J Med. 2015;373:1607–17. doi: 10.1056/NEJMoa140645926488692
46. Menéndez C, Bardají A, Sigauque B, Romagosa C, Sanz S, Serra-Casas E, et al. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS ONE. 2008;3:e1934. doi: 10.1371/journal.pone.000193418398460
47. Minja DTR, Schmiegelow C, Mmbando B, Boström S, Oesterholt M, Magistrado P, et al. Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania. Emerg Infect Dis. 2013;19.